Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

18F-Fluciclovine PET/CT has become a common diagnostic imaging study used in the evaluation of biochemical recurrence in prostate cancer since its approval in 2016. We present a case report of an 82-year-old man with history of both prostate and bladder cancer who presented for a fluciclovine study due to rising PSA levels. There was incidental detection of focal penile activity, and a subsequent urethral biopsy performed showed urothelial carcinoma, which was also seen on a subsequent MRI study.

Original languageEnglish (US)
Pages (from-to)e114-e115
JournalClinical nuclear medicine
Volume46
Issue number2
DOIs
StatePublished - 2021

Keywords

  • F-fluciclovine PET/CT
  • prostate cancer
  • urothelial carcinoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT'. Together they form a unique fingerprint.

Cite this